Multiple Sclerosis (MS) Drugs
Rebif ® Unknowns (interferon beta-1a)
Safety and Efficacy
The safety and efficacy of Rebif ® beyond 2 years is unknown.
Efficacy of Rebif ® in chronic progressive or secondary
progressive multiple sclerosis has not been established.
No virus has ever been isolated as the cause of Multiple Sclerosis.
What is Multiple Sclerosis?
Multiple sclerosis is currently thought to be an autoimmune disease. An autoimmune disease is one where the body's immune system is thought to attack its own cells and therefore cause damage.... Read More